Tag: Competition

Displaying 61 - 80 of 2689 results.

Pages

WHAT:The U.S. Federal Trade Commission will host a Roundtable, Streamlining Licensing Across State Lines: Initiatives to Enhance Occupational License Portability. The event will explore options for enhancing the portability of occupational licenses.WHEN:Thursday, July 27, 2:00 p.m.–4:00 p.m.
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen released a summary of the agency’s major accomplishments since President Trump named her to the position in January. “I have pursued my long-held principles by promoting economic liberty, protecting consumers (including the military...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business would (1) reduce current competition in the United States for the...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle Federal Trade Commission charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business is anticompetitive.According to a complaint filed by...
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that she has selected D. Bruce Hoffman, a partner at the law firm of Shearman & Sterling LLP, to be the Acting Director of the FTC’s Bureau of Competition, effective August 7, 2017.
Federal Trade Commission staff submitted an additional public comment to the Tennessee Department of Health that opposes issuing a certificate of public advantage (COPA) to Mountain States Health Alliance and Wellmont Health System that would allow the two companies to merge.
Discussion of the significant negative effects on hospital prices, quality of care, and the availability of services likely to result from the merger of Mountain States and Wellmont, and of deficiencies in three reports filed by the applicants.
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen has appointed Neil Alan Chilson as the agency’s acting Chief Technologist.Chilson will be primarily responsible for advising Chairman Ohlhausen and the Commission on technology matters, including the FTC’s use of technology, technical...
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen announced that FTC Bureau of Economics Director Ginger Zhe Jin is departing the agency to return to the University of Maryland and has named Michael G. Vita Acting Director of the Bureau.“Ginger was an outstanding Bureau Director,...
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. granting West Therapeutic Development, LLC certain rights to develop and market the specialty drug Synacthen Depot in the United States.Synacthen Depot contains a synthetic version of adrenocorticotropic...
Following a public comment period, the Federal Trade Commission has approved an application from LaFargeHolcim, Ltd to amend several agreements that were part of a 2015 FTC order settling charges that the $25 billion merger of Holcim Ltd. and Lafarge S.A. would likely harm competition in the United...
“The parties’ decision to abandon this transaction is a clear win for American consumers,” said Markus H. Meier, Acting Director of the Bureau of Competition. “For years, the vigorous competition between DraftKings and FanDuel has spurred innovation and favorable pricing. In brief, consumers...
The FTC’s Economic Liberty Task Force has announced the agenda for its first Roundtable, Streamlining Licensing Across State Lines
The Federal Trade Commission has approved the appointment of Quantic Regulatory Services, LLC as monitor in its case alleging that Endo Pharmaceuticals Inc. violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm.

Pages